Concepedia

Author

Sheila Sunga

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

S. Sunga, Sheila Sunga

4

Publications

522

Citations

4

H-Index

0

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)
SS

About

Sheila Sunga is an author at Merck & Co., Inc., Rahway, NJ, USA (United States).

Sheila Sunga

×

3

Publications

515

Citations

3

H-Index

YearCitations

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

Thomas Seck, Michael A. Nauck, Sheila Sunga,

International Journal of Clinical Practice

2010

202

Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The <scp>VERTIS FACTORIAL</scp> randomized trial

Richard E. Pratley, Roy Eldor, Annaswamy Raji,

Diabetes Obesity and Metabolism

2017

158

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Pablo Aschner, H. L. Katzeff, Hongquan Guo,

Diabetes Obesity and Metabolism

2009

155

Page 1